Well Lead Medical Statistics

Total Valuation

SHA:603309 has a market cap or net worth of CNY 3.53 billion. The enterprise value is 3.61 billion.

Market Cap	3.53B
Enterprise Value	3.61B

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	May 29, 2025

Share Statistics

SHA:603309 has 292.87 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class	292.87M
Shares Outstanding	292.87M
Shares Change (YoY)	-0.31%
Shares Change (QoQ)	+0.69%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	15.02%
Float	141.50M

Valuation Ratios

The trailing PE ratio is 15.47 and the forward PE ratio is 12.19.

PE Ratio	15.47
Forward PE	12.19
PS Ratio	2.28
PB Ratio	1.80
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	12.50
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.78, with an EV/FCF ratio of -271.83.

EV / Earnings	15.85
EV / Sales	2.33
EV / EBITDA	10.78
EV / EBIT	13.61
EV / FCF	-271.83

Financial Position

The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.27.

Current Ratio	2.12
Quick Ratio	1.66
Debt / Equity	0.27
Debt / EBITDA	1.60
Debt / FCF	-40.32
Interest Coverage	21.04

Financial Efficiency

Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 6.56%.

Return on Equity (ROE)	12.27%
Return on Assets (ROA)	5.85%
Return on Invested Capital (ROIC)	6.56%
Return on Capital Employed (ROCE)	11.01%
Revenue Per Employee	590,504
Profits Per Employee	86,980
Employee Count	2,622
Asset Turnover	0.55
Inventory Turnover	5.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.42% in the last 52 weeks. The beta is -0.09, so SHA:603309's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	+0.42%
50-Day Moving Average	11.79
200-Day Moving Average	11.92
Relative Strength Index (RSI)	52.63
Average Volume (20 Days)	3,166,630

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:603309 had revenue of CNY 1.55 billion and earned 228.06 million in profits. Earnings per share was 0.78.

Revenue	1.55B
Gross Profit	673.46M
Operating Income	265.60M
Pretax Income	271.85M
Net Income	228.06M
EBITDA	327.82M
EBIT	265.60M
Earnings Per Share (EPS)	0.78

Full Income Statement

Balance Sheet

The company has 475.91 million in cash and 536.18 million in debt, giving a net cash position of -60.27 million or -0.21 per share.

Cash & Cash Equivalents	475.91M
Total Debt	536.18M
Net Cash	-60.27M
Net Cash Per Share	-0.21
Equity (Book Value)	1.96B
Book Value Per Share	6.64
Working Capital	471.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 282.84 million and capital expenditures -296.14 million, giving a free cash flow of -13.30 million.

Operating Cash Flow	282.84M
Capital Expenditures	-296.14M
Free Cash Flow	-13.30M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 43.50%, with operating and profit margins of 17.15% and 14.73%.

Gross Margin	43.50%
Operating Margin	17.15%
Pretax Margin	17.56%
Profit Margin	14.73%
EBITDA Margin	21.17%
EBIT Margin	17.15%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 4.14%.

Dividend Per Share	0.50
Dividend Yield	4.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	68.33%
Buyback Yield	0.31%
Shareholder Yield	4.46%
Earnings Yield	6.45%
FCF Yield	-0.38%

Dividend Details

Stock Splits

The last stock split was on May 25, 2020. It was a forward split with a ratio of 1.3.

Last Split Date	May 25, 2020
Split Type	Forward
Split Ratio	1.3

Scores

SHA:603309 has an Altman Z-Score of 3.95.

Altman Z-Score	3.95
Piotroski F-Score	n/a